Sangamo shareholders approve increase in authorized shares and equity plan share reserve at annual meeting

SANGAMO THERAPEUTICS, INC

Authorized common stock increased from 640M to 960M shares (320M increase).
2018 Equity Incentive Plan amended to add 11M shares to the reserve (total available now ~49.3M plus returning shares).
All nine director nominees elected; advisory 'say-on-pay' passed with 101.3M votes for vs 15.1M against.
Ratification of Ernst & Young as independent auditor for FY2024 approved with 151.1M votes for.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.